Literature DB >> 22942873

Sub-Chronic Oral Exposure to Iridium (III) Chloride Hydrate in Female Wistar Rats: Distribution and Excretion of the Metal.

Ivo Iavicoli1, Luca Fontana, Antonio Bergamaschi, Marcelo Enrique Conti, Anna Pino, Daniela Mattei, Beatrice Bocca, Alessandro Alimonti.   

Abstract

Iridium tissue distribution and excretion in female Wistar rats following oral exposure to iridium (III) chloride hydrate in drinking water (from 1 to 1000 ng/ml) in a sub-chronic oral study were determined. Samples of urine, feces, blood and organs (kidneys, liver, lung, spleen and brain) were collected at the end of exposure. The most prominent fractions of iridium were retained in kidney and spleen; smaller amounts were found in lungs, liver and brain. Iridium brain levels were lower than those observed in other tissues but this finding can support the hypothesis of iridium capability to cross the blood brain barrier. The iridium kidney levels rose significantly with the administered dose. At the highest dose, important amounts of the metal were found in serum, urine and feces. Iridium was predominantly excreted via feces with a significant linear correlation with the ingested dose, which is likely due to low intestinal absorption of the metal. However, at the higher doses iridium was also eliminated through urine. These findings may be useful to help in the understanding of the adverse health effects, particularly on the immune system, of iridium dispersed in the environment as well as in identifying appropriate biological indices of iridium exposure.

Entities:  

Keywords:  Distribution; Excretion; Iridium; Rats; Sub-chronic exposure

Year:  2012        PMID: 22942873      PMCID: PMC3430401          DOI: 10.2203/dose-response.11-052.Iavicoli

Source DB:  PubMed          Journal:  Dose Response        ISSN: 1559-3258            Impact factor:   2.658


  30 in total

1.  Lead differentially modifies cytokine production in vitro and in vivo.

Authors:  Y Heo; P J Parsons; D A Lawrence
Journal:  Toxicol Appl Pharmacol       Date:  1996-05       Impact factor: 4.219

2.  Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs.

Authors:  Wolfgang G Kreyling; Manuela Semmler-Behnke; Jürgen Seitz; Wilfried Scymczak; Alexander Wenk; Paula Mayer; Shinji Takenaka; Günter Oberdörster
Journal:  Inhal Toxicol       Date:  2009-07       Impact factor: 2.724

3.  Indium and iridium allergy in patients exposed to dental alloys.

Authors:  J A Marcusson; K Cederbrant; J Heilborn
Journal:  Contact Dermatitis       Date:  1998-05       Impact factor: 6.600

4.  The effects of iridium on the renal function of female Wistar rats.

Authors:  Ivo Iavicoli; Luca Fontana; Alessandro Marinaccio; Alessandro Alimonti; Anna Pino; Antonio Bergamaschi; Edward J Calabrese
Journal:  Ecotoxicol Environ Saf       Date:  2011-07-20       Impact factor: 6.291

5.  Impact of developmental lead exposure on splenic factors.

Authors:  Jane Kasten-Jolly; Yong Heo; David A Lawrence
Journal:  Toxicol Appl Pharmacol       Date:  2010-06-11       Impact factor: 4.219

6.  Below background levels of blood lead impact cytokine levels in male and female mice.

Authors:  I Iavicoli; G Carelli; E J Stanek; N Castellino; E J Calabrese
Journal:  Toxicol Appl Pharmacol       Date:  2005-11-10       Impact factor: 4.219

7.  The determination of low lead levels in the bone of lead-depleted mice by graphite furnace atomic absorption spectrometry.

Authors:  I Iavicoli; G Carelli; N Castellino; G Schlemmer
Journal:  Fresenius J Anal Chem       Date:  2001-08

8.  In vivo the environmental pollutants lead and mercury induce oligoclonal T cell responses skewed toward type-2 reactivities.

Authors:  Y Heo; W T Lee; D A Lawrence
Journal:  Cell Immunol       Date:  1997-08-01       Impact factor: 4.868

9.  Differential effects of lead and cAMP on development and activities of Th1- and Th2-lymphocytes.

Authors:  Y Heo; W T Lee; D A Lawrence
Journal:  Toxicol Sci       Date:  1998-06       Impact factor: 4.849

10.  Contact urticaria with anaphylactic reactions caused by occupational exposure to iridium salt.

Authors:  A Bergman; U Svedberg; E Nilsson
Journal:  Contact Dermatitis       Date:  1995-01       Impact factor: 6.600

View more
  1 in total

1.  Novel iridium (III)‑derived organometallic compound for the inhibition of human platelet activation.

Authors:  Kou-Gi Shyu; Marappan Velusamy; Chih-Wei Hsia; Chih-Hao Yang; Chih-Hsuan Hsia; Duen-Suey Chou; Thanasekaran Jayakumar; Joen-Rong Sheu; Jiun-Yi Li
Journal:  Int J Mol Med       Date:  2018-02-07       Impact factor: 4.101

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.